West Pharmaceutical Services (WST) Income from Continuing Operations (2009 - 2026)
West Pharmaceutical Services (WST) posted Income from Continuing Operations of 147900000.0 for Q2 2026, up 9.23% sequentially from 135400000.0 in Q1 2026, and up 16.64% YoY from 126800000.0 in Q2 2025.
West Pharmaceutical Services (WST) Income from Continuing Operations (2009 - 2026) Analysis & Trends
West Pharmaceutical Services has reported Income from Continuing Operations for 18 years, with the latest figure at 147900000.0 in Q2 2026.
- Quarterly Income from Continuing Operations rose 16.64% year-over-year to 147900000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 549400000.0 (up 16.05% YoY) and the FY2025 annual result came in at 479300000.0, changed 0.27% from the prior year.
- Income from Continuing Operations advanced to 147900000.0 in Q2 2026 per WST's latest filing, from 135400000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 183000000.0 in Q2 2022 and troughed at 86400000.0 in Q1 2025.
- A 5-year average of 132305555.56 and a median of 132900000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2026: Income from Continuing Operations tumbled 32.43% in 2022, then soared 56.71% in 2026.
- Over 5 years, Income from Continuing Operations stood at 99800000.0 in 2022, then surged by 33.97% to 133700000.0 in 2023, then slipped by 4.19% to 128100000.0 in 2024, then rose by 0.08% to 128200000.0 in 2025, then advanced by 15.37% to 147900000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 147900000.0, 135400000.0, and 128200000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 108.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 147.90 Mn |
| Mar 31, 2026 | 135.40 Mn |
| Dec 31, 2025 | 128.20 Mn |
| Sep 30, 2025 | 137.90 Mn |
| Jun 30, 2025 | 126.80 Mn |
| Mar 31, 2025 | 86.40 Mn |
| Dec 31, 2024 | 128.10 Mn |
| Sep 30, 2024 | 132.10 Mn |
| Jun 30, 2024 | 106.80 Mn |
| Mar 31, 2024 | 111.00 Mn |
| Dec 31, 2023 | 133.70 Mn |
| Sep 30, 2023 | 157.60 Mn |
| Jun 30, 2023 | 150.10 Mn |
| Mar 31, 2023 | 134.30 Mn |
| Dec 31, 2022 | 99.80 Mn |
| Sep 30, 2022 | 115.80 Mn |
| Jun 30, 2022 | 183.00 Mn |
| Mar 31, 2022 | 166.60 Mn |
| Dec 31, 2021 | 147.70 Mn |
| Sep 30, 2021 | 169.10 Mn |